| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 135,041 | 133,041 | 152,900 | 163,831 | | Cost of Revenue | 43,947 | 43,519 | 53,718 | 51,702 | | | Gross Profit | 91,094 | 89,522 | 99,182 | 112,129 | | | Operating Expenses | | Research Development |
-
| (32,502) | 13,691 | 18,811 | | Selling General and Administrative | 61,150 | 88,235 | 89,279 | 57,672 | | Non Recurring |
-
| 322,000 |
-
|
-
| | Others | 6,252 | 6,204 | 7,139 | 7,779 | | | | Total Operating Expenses |
-
| 383,937 |
-
|
-
| | | | Operating Income or Loss | 23,692 | (294,415) | (10,927) | 27,867 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (1,925) | (366) | 1,413 | | Earnings Before Interest And Taxes | 23,692 | (296,340) | (11,293) | 29,280 | | Interest Expense | 166 |
-
|
-
|
-
| | Income Before Tax | 23,526 | (296,340) | (11,293) | 29,280 | | Income Tax Expense | 10,309 | (40,197) | (13,292) | 12,791 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,217 | (256,143) | 1,999 | 16,489 | | | Non-recurring Events | | Discontinued Operations |
-
| 4,376 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,217 | (251,767) | 1,999 | 16,489 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,217 | ($251,767) | $1,999 | $16,489 |
|
0.45% Nasdaq 
0.20%
Income Statement
